T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
E.W. Scripps
SSP
$310M
| $594K | ﹤0.01% |
30,698
-3,900
| -11% | -$75.3K |
|
2302
Sonic Automotive
SAH
$2.56B
| $593K | ﹤0.01% |
11,991
-395
| -3% | -$19.8K |
|
2303
United Fire Group
UFCS
$1.37B
| $592K | ﹤0.01% |
25,514
-4,391
| -15% | -$98.7K |
|
2304
Coherus Oncology
CHRS
$181M
| $589K | ﹤0.01% |
36,934
-1,144
| -3% | -$20K |
|
2305
Li Auto
LI
$12B
| $587K | ﹤0.01% |
18,300
| – | – |
|
2306
Fidelity MSCI Information Technology Index ETF
FTEC
$21.6B
| $582K | ﹤0.01% |
4,302
| – | – |
|
2307
Ocugen
OCGN
$458M
| $581K | ﹤0.01% |
127,633
+21,576
| +20% | +$163K |
|
2308
Vishay Precision Group
VPG
$908M
| $578K | ﹤0.01% |
15,565
-191
| -1% | -$6.83K |
|
|
AGR
2309
DELISTED
Avangrid, Inc.
AGR
| $577K | ﹤0.01% |
11,564
-2,973
| -20% | -$151K |
|
|
AVYA
2310
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $575K | ﹤0.01% |
29,039
-5,868
| -17% | -$116K |
|
2311
Inovio Pharmaceuticals
INO
$93M
| $574K | ﹤0.01% |
9,587
-4,062
| -30% | -$325K |
|
|
MCFE
2312
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $571K | ﹤0.01% |
22,144
-2,926,909
| -99% | -$70.5M |
|
2313
Nice
NICE
$5.78B
| $570K | ﹤0.01% |
1,876
+226
| +14% | +$65.2K |
|
2314
PBF Energy
PBF
$8.81B
| $568K | ﹤0.01% |
43,767
-1,507
| -3% | -$20.9K |
|
2315
Comtech Telecommunications
CMTL
$52.1M
| $567K | ﹤0.01% |
23,931
-434
| -2% | -$10.6K |
|
2316
Gogo Inc
GOGO
$377M
| $567K | ﹤0.01% |
41,887
+9,526
| +29% | +$142K |
|
2317
GoPro
GPRO
$117M
| $567K | ﹤0.01% |
55,016
-2,130
| -4% | -$21.1K |
|
2318
Krystal Biotech
KRYS
$9.72B
| $567K | ﹤0.01% |
8,105
+3,886
| +92% | +$226K |
|
|
ACRE
2319
Ares Commercial Real Estate
ACRE
$261M
| $566K | ﹤0.01% |
38,937
-732
| -2% | -$11.2K |
|
2320
Koppers
KOP
$857M
| $566K | ﹤0.01% |
18,092
+60
| +0.3% | +$1.96K |
|
2321
Lexicon Pharmaceuticals
LXRX
$1.04B
| $566K | ﹤0.01% |
143,632
+14,064
| +11% | +$68.3K |
|
|
TBI
2322
Trueblue
TBI
$302M
| $563K | ﹤0.01% |
20,346
+3,170
| +18% | +$89.7K |
|
2323
West Bancorporation
WTBA
$511M
| $563K | ﹤0.01% |
18,125
+663
| +4% | +$20.9K |
|
|
HBMD
2324
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $563K | ﹤0.01% |
25,851
-238
| -0.9% | -$5.09K |
|
|
DEA
2325
Easterly Government Properties
DEA
$1.16B
| $559K | ﹤0.01% |
9,750
-1,292
| -12% | -$69.8K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.